关于加快中国创新医药学学科建设的思考与建议

黄慧瑶; 蒋雅乐; 余伟杰; 唐玉; 徐兵河; 李宁

doi:10.3981/j.issn.1000-7857.2023.18.009

PDF(465 KB)

科技导报 ›› 2023, Vol. 41 ›› Issue (18) : 67-71. DOI: 10.3981/j.issn.1000-7857.2023.18.009

专题：癌症防治

关于加快中国创新医药学学科建设的思考与建议

作者信息 -

国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院，药物临床试验研究中心，北京 100021

作者简介:

黄慧瑶，副研究员，研究方向为临床研究统计设计和分析、临床流行病学及监管科学等，电子信箱：huanghy314@sina.cn；蒋雅乐（共同第一作者），博士研究生，研究方向为抗肿瘤新药，电子信箱：yalejiang@cicams.ac.cn

Reflections and insights on accelerating the discipline construction of innovative pharmaceutical medicine in China

Author information -

Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

摘要

分析了中国创新医药学学科建设的必要性、存在的主要问题和可借鉴的国外经验，提出了加快推动中国创新医药学学科建设的思考与建议。呼吁凝聚全行业、全社会力量，共同创造利于中国创新医药学人才培养和发展的体系建立，为中国医药创新化发展及全球化发展提供人才保障。

Abstract

Thoughts and suggestions on accelerating the construction of innovative pharmaceutical medicine discipline in China were put forward by systematically analyzing the necessity of the discipline in China, the main existing problems, and the foreign experiences. This paper also called for gathering the strength of the whole industry and society to create a system conducive to the cultivation and development of talents in the innovative pharmaceutical medicine in China, so as to provide talent resources for innovation and globalization of pharmaceutical medicine development.

导出引用

黄慧瑶, 蒋雅乐, 余伟杰, 唐玉, 徐兵河, 李宁. 关于加快中国创新医药学学科建设的思考与建议[J]. 科技导报, 2023, 41(18): 67-71 https://doi.org/10.3981/j.issn.1000-7857.2023.18.009

HUANG Huiyao, JIANG Yale, YU Weijie, TANG Yu, XU Binghe, LI Ning. Reflections and insights on accelerating the discipline construction of innovative pharmaceutical medicine in China[J]. Science & Technology Review, 2023, 41(18): 67-71 https://doi.org/10.3981/j.issn.1000-7857.2023.18.009

参考文献

[1] Li G, Liu Y, Hu H, et al. Evolution of innovative drug R&D in China[J]. Nature Reviews Drug Discovery, 2022, 21(8): 553-557.
[2] Huang H, Wu D, Miao H, et al. Accelerating the integration of China into the global development of innovative anticancer drugs[J]. The Lancet Oncology, 2022, 23(11): 515-520.
[3] Informa Pharma Intelligence. 中国临床试验格局白皮书[R/OL]. (2023-09) [2023-09-13]. https://pages.pharmaintelligence.informa.com/mandarin-china-landscape.
[4] Citeline. 2023 年医药研发年度回顾[R/OL]. (2023-07)[2023-09-13]. https://euamth. com/Uploads/images/2023/07/06/1688620177_news2_file.
[5] 刘玉秀 . 临床研究的认识观和方法学[J]. 医学研究生学报, 2022, 35(2): 113-117.
[6] Ni J, Zhao J, Ung C O, et al. Obstacles and opportunities in Chinese pharmaceutical innovation[J]. Global Health, 2017, 13(1): 21.
[7] IFAPP. Our history[EB/OL]. [2023-09-13]. https://ifapp.org/about/history.
[8] Kerpel-Fronius S, Rosenkranz B, Allen E, et al. Education and training for medicines development, regulation, and clinical research in emerging countries[J]. Front Pharmacol, 2015, 14(6): 80.
[9] Stonier P D, Silva H, Boyd A, et al. Evolution of the development of core competencies in pharmaceutical medicine and their potential use in education and training[J]. Front Pharmacol, 2020, 19(11): 282.
[10] Peter S, Honorio S, Herman L. Pharmaceutical medicine: History, global status, evolution and development[J]. International Journal of Pharmaceutical Medicine, 2007, 21(4): 253-262.
[11] Criscuolo D. Postgraduate courses in pharmaceutical medicine in Italy[J]. Frontiers of Medicine, 2017, 4: 79.
[12] 王安心, 夏雪, 朱金巧, 等 . 制药医学发展概况及学科建设展望[J]. 首都医科大学学报, 2023, 44(1): 5.
[13] Silva H, Stonier P, Buhler F, et al. Core competencies for pharmaceutical physicians and drug development scientists[J]. Front Pharmacol, 2013, 4: 105.
[14] Imamura K, Criscuolo D, Jurczynska A, et al. International perception of competence, education, and training needs among biomedical professionals involved in medicines development[J]. Front Pharmacol, 2019, 10: 188.
[15] Custers E, Cate O T. The history of medical education in Europe and the United States, with respect to time and proficiency[J]. Academic Medicine, 2018, 93(3): 49-54.
[16] FPM. About[EB/OL]. [2023-09-13]. https://www.fpm.org.uk/about.
[17] 赵一鸣, 曾琳, 李楠 . 临床研究的四个基本特征[J]. 中华医学杂志, 2012, 36: 2521-2523.
[18] Areephanthu C J, Bole R, Stratton T, et al. Impact of professional student mentored research fellowship on medical education and academic medicine career path[J]. Clinical and Translational Science, 2015, 8(5): 479-83.
[19] 王莉, 张典, 史传道, 等 . 医学院校临床研究课程现状与设置策略[J]. 癌症, 2023, 42(2): 4.
[20] 代倩倩, 王燕平, 商洪才, 等 . 从循证医学与转化医学谈中医药临床研究发展[J]. 生物医学转化, 2022, 3: 3.
[21] 冯铁男, 刘怡婷, 缪鑫, 等 . 中美关于临床医师临床研究方法学素养培训的比较研究[J]. 中华医学教育探索杂志, 2022, 1: 1-5.
[22] 花琳琳, 冯宇, 林粤婷, 等 . 高校附属医院医务工作者临床研究培训需求及课程设置分析[J]. 河南医学研究, 2021, 30(16): 3.